| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 24 hours |
| 被験者数 | 60 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44, 45-64, 65+ |
| 体型 | 肥満, 平均 |
この研究の注釈：
Supplementation of 1000mg of isolated rebaudioside A failed to significantly influence blood pressure or heart rate in otherwise healthy persons with normal to low blood pressure.
Apparent Lack Of Pharmacological Effect Of Steviol Glycosides Used As Sweeteners In Humans. A Pilot Study Of Repeated Exposures In Some Normotensive And Hypotensive Individuals And In Type 1 And Type 2 Diabetics
| 効果 | なし |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 72 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44, 45-64 |
| 体型 | 肥満, 平均 |
この研究の注釈：
No significant effects of 750mg steviosides daily for 3 months aside from a small reduction in blood pressure and glucose seen in the type 1 diabetic cohort.
A Double-blind Placebo-controlled Study Of The Effectiveness And Tolerability Of Oral Stevioside In Human Hypertension
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 6+ ヶ月 |
| 被験者数 | 100 |
| 性別 | 男女 |
| 年齢 | 45-64 |
| 体型 | 平均 |
この研究の注釈：
750mg stevioside daily for 1 year was able to reduce blood pressure in hypertensive persons, but failed to influence any other biomarker in serum.
Efficacy And Tolerability Of Oral Stevioside In Patients With Mild Essential Hypertension: A Two-year, Randomized, Placebo-controlled Study
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 6+ ヶ月 |
| 被験者数 | 168 |
| 性別 | 男女 |
| 年齢 | 45-64, 65+ |
| 体型 | 肥満, 平均 |
この研究の注釈：
Chronic (2 year) ingestion of stevia as part of a diet in hypertensive persons resulted in reduced blood pressure relative to control (around 7% for both systolic and diastolic) and a lesser frequency of left ventricle hypertrophy.